Prof De Lorenzo attended the 2018 WIN Symposium where he had an interview with ecancer about what the European Cancer Patient Coalition and Cancer Control Joint Action are doing to eradicate different access to cancer medications between different places.


ECPC is an active member in the Worldwide Innovative Networking (WIN) Consortium in personalized cancer medicine, contributing to the mission of rapidly translating personalized cancer medicine discoveries into standards of patient care worldwide.